TC
MRNA icon

TownSquare Capital’s Moderna MRNA Stock Holding History

TownSquare Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,118
Closed -$230K – 1229
2025
Q1 		$230K Buy
8,118
+2,078
+34% +$73.7K ﹤0.01% 1481
2024
Q4 		$251K Buy
6,040
+752
+14% +$35.9K ﹤0.01% 1337
2024
Q3 		$353K Buy
5,288
+1,583
+43% +$145K ﹤0.01% 1099
2024
Q2 		$440K Buy
3,705
+1,618
+78% +$205K 0.01% 936
2024
Q1 		$222K Sell
2,087
-263
-11% -$26.5K ﹤0.01% 1105
2023
Q4 		$234K Sell
2,350
-285
-11% -$24K ﹤0.01% 1000
2023
Q3 		$272K Buy
2,635
+609
+30% +$67.9K 0.01% 945
2023
Q2 		$246K Buy
2,026
+501
+33% +$66.8K ﹤0.01% 945
2023
Q1 		$234K Sell
1,525
-377
-20% -$62.2K 0.01% 899
2022
Q4 		$342K Buy
+1,902
New +$311K 0.01% 768
2022
Q2 		– Sell
-1,588
Closed -$274K – 755
2022
Q1 		$274K Sell
1,588
-2,659
-63% -$448K 0.01% 609
2021
Q4 		$1.08M Sell
4,247
-13,059
-75% -$3.82M 0.03% 351
2021
Q3 		$6.66M Buy
17,306
+1,532
+10% +$565K 0.19% 96
2021
Q2 		$3.68M Sell
15,774
-11,417
-42% -$2.04M 0.12% 155
2021
Q1 		$3.56M Buy
27,191
+8,641
+47% +$1.25M 0.14% 135
2020
Q4 		$1.94M Buy
+18,550
New +$1.88M 0.09% 195

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TownSquare Capital's MRNA Position: Q2 2025 in Review

TownSquare Capital sold out of Moderna (MRNA) in Q2 2025, closing a stake of 8,118 shares — an estimated $230K sold.

TownSquare Capital first reported a position in MRNA in Q4 2020 and held it in 16 quarters. The position peaked at $6.66M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • TownSquare Capital reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 8,118 Moderna shares in Q2 2025, an estimated $230K.
  • TownSquare Capital first reported a position in Moderna in Q4 2020 and held it in 16 quarters.
  • TownSquare Capital's Moderna position peaked at $6.66M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.